Healthtech Solutions, Inc. Announces Appointment of Paul Mann to the Board of Directors
July 20, 2021 16:30 ET
|
Healthtech Solutions, Inc.
NEW YORK, July 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthtech Solutions, Inc. (OTC: HLTT) (“Healthtech” or the “Company”), an innovative portfolio-model life sciences company focused on...
Healthtech Solutions, Inc. Adds Distinguished Leadership To Its Board of Directors
July 08, 2021 08:00 ET
|
Healthtech Solutions, Inc.
NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Healthtech Solutions, Inc. (OTC: HLTT) (“Healthtech” or the “Company”), an innovative portfolio-model life sciences company focused on...
Healthtech Solutions, Inc. Bolsters Management and Board with Two New Appointments
July 01, 2021 08:00 ET
|
Healthtech Solutions, Inc.
NEW YORK, July 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthtech Solutions, Inc. (OTC: HLTT) (“Healthtech” or the “Company”), an innovative portfolio-model life sciences company focused on...
HEALTHTECH SOLUTIONS, INC. ANNOUNCES CONTRACT TO ACQUIRE VARIAN BIOPHARMACEUTICALS, A PRECISION ONCOLOGY COMPANY
March 31, 2021 15:11 ET
|
Healthtech Solutions, Inc.
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthtech Solutions, Inc. (OTC: HLTT) (“HLTT” or the “Company”) today announces that it has entered into an agreement to acquire a...
Healthtech Solutions, Inc. (HLTT), Parent Company of Cutting-Edge Medical Technology Companies, Files Reg A With SEC
March 17, 2021 08:30 ET
|
Healthtech Solutions, Inc.
March 8, 2021, filing to raise up to $75 million. Maximum of 1,500,000 shares of Series B preferred stock offered at price of $50 per share.Healthtech Solutions, Inc. is organized to pursue...
Healthtech Solutions, Inc. (HLTT), Parent Company of Medi-Scan Inc., Announces Incorporation of a New Subsidiary Called RevHeart, Inc.
March 16, 2021 08:30 ET
|
Healthtech Solutions, Inc.
New subsidiary will further the Company’s research into treating COVID-related heart muscle injury. A patent has been filed for a therapy to ameliorate and potentially repair myocardial damage. NEW...